Stock listing
Xetra:RGN Repligen Corporation Aktie
German listing (Xetra) of Repligen Corporation · home listing NASDAQ:RGEN
Follow Repligen Corporation into a list and get an email when it puts out news.
Home listing price · NASDAQ:RGEN
$163.81 USD -8.86 (-5.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RGEN
- Day range
- $162.50 – $169.61 USDNov 20, 2026
- Volume
- 697,683 sharesNov 20, 2026
- Market cap
- $10.47B USDAt the close on Nov 20, 2026 · price × 63.92M shares outstanding
- 52-week range
- $100.99 – $198.87 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $208.5M USDMedian day 1.08M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RGEN · Home | $163.81 USD | -8.86 (-5.1%) | 697,683 | $169.61 | $169.61 | $162.50 | $172.67 | Close on Nov 20, 2026 |
| Frankfurt:RGN | €154.35 EUR | -1.65 (-1.1%) | — | €157.00 | €157.00 | €154.35 | €156.00 | Close on Nov 19, 2026 |
| Munich:RGN | €156.05 EUR | -0.50 (-0.3%) | — | €156.05 | €156.05 | €156.05 | €156.55 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RGEN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $163.81 | -8.86 | -5.1% | $169.61 | $169.61 | $162.50 | 697,683 | |
| $172.67 | +10.49 | +6.5% | $163.03 | $174.44 | $163.01 | 1,298,264 | |
| $162.18 | -0.60 | -0.4% | $162.78 | $164.91 | $160.27 | 770,857 | |
| $162.78 | -5.01 | -3.0% | $166.14 | $166.79 | $162.48 | 575,422 | |
| $167.79 | +1.27 | +0.8% | $168.09 | $168.48 | $165.26 | 510,106 | |
| $166.52 | -6.10 | -3.5% | $167.71 | $169.40 | $164.17 | 802,964 | |
| $172.62 | -1.36 | -0.8% | $176.11 | $178.50 | $171.99 | 1,000,614 | |
| $173.98 | -4.96 | -2.8% | $176.76 | $178.38 | $173.87 | 678,643 | |
| $178.94 | +5.45 | +3.1% | $174.29 | $181.02 | $172.39 | 1,096,247 | |
| $173.49 | +5.01 | +3.0% | $169.35 | $175.00 | $168.05 | 1,069,907 | |
| $168.48 | -9.72 | -5.5% | $175.60 | $176.66 | $168.03 | 1,332,421 | |
| $178.20 | -0.07 | 0.0% | $183.40 | $188.50 | $174.39 | 1,058,127 | |
| $178.27 | +5.32 | +3.1% | $175.54 | $181.55 | $173.00 | 1,019,566 | |
| $172.95 | -3.99 | -2.3% | $178.12 | $178.12 | $172.54 | 1,576,318 | |
| $176.94 | -11.70 | -6.2% | $175.37 | $180.31 | $171.23 | 4,472,060 | |
| $188.64 | +3.95 | +2.1% | $188.42 | $191.05 | $185.28 | 890,263 | |
| $184.69 | +8.89 | +5.1% | $173.54 | $185.88 | $173.54 | 1,447,759 | |
| $175.80 | -4.37 | -2.4% | $168.34 | $180.00 | $164.88 | 2,114,806 | |
| $180.17 | +3.24 | +1.8% | $176.93 | $181.46 | $175.80 | 1,176,930 | |
| $176.93 | -1.78 | -1.0% | $178.30 | $179.54 | $174.90 | 1,066,100 | |
| $178.71 | -1.30 | -0.7% | $179.45 | $185.03 | $175.96 | 1,272,500 | |
| $180.01 | +1.13 | +0.6% | $174.37 | $183.49 | $172.00 | 903,900 | |
| $178.88 | +2.45 | +1.4% | $176.50 | $180.67 | $174.37 | 877,700 | |
| $176.43 | +1.01 | +0.6% | $177.82 | $178.66 | $174.26 | 769,100 | |
| $175.42 | -8.75 | -4.8% | $183.81 | $186.00 | $172.39 | 1,213,300 | |
| $184.17 | +5.97 | +3.4% | $178.28 | $185.99 | $177.49 | 1,043,100 | |
| $178.20 | +2.78 | +1.6% | $175.42 | $181.07 | $175.39 | 1,216,900 | |
| $175.42 | +2.91 | +1.7% | $172.51 | $177.96 | $169.73 | 1,259,300 | |
| $172.51 | -1.37 | -0.8% | $171.73 | $173.82 | $169.90 | 899,600 | |
| $173.88 | +10.04 | +6.1% | $164.21 | $174.82 | $164.21 | 1,339,900 | |
| $163.84 | -3.38 | -2.0% | $164.00 | $164.65 | $157.44 | 1,226,700 | |
| $167.22 | -7.64 | -4.4% | $174.75 | $175.04 | $165.99 | 2,630,100 | |
| $174.86 | -14.64 | -7.7% | $191.90 | $194.36 | $174.36 | 1,704,600 | |
| $189.50 | +7.80 | +4.3% | $178.75 | $191.26 | $178.61 | 1,613,600 | |
| $181.70 | +4.47 | +2.5% | $179.32 | $186.52 | $178.00 | 1,460,500 | |
| $177.23 | -15.00 | -7.8% | $194.00 | $194.00 | $177.12 | 1,945,700 | |
| $192.23 | -2.34 | -1.2% | $193.09 | $195.61 | $190.97 | 730,400 | |
| $194.57 | +0.48 | +0.2% | $196.00 | $196.65 | $190.98 | 1,139,000 | |
| $194.09 | +4.41 | +2.3% | $187.25 | $198.87 | $187.11 | 1,567,100 | |
| $189.68 | -0.97 | -0.5% | $189.92 | $191.51 | $186.91 | 1,502,400 | |
| $190.65 | +6.12 | +3.3% | $184.10 | $192.49 | $183.75 | 1,602,600 | |
| $184.53 | -2.22 | -1.2% | $186.38 | $188.95 | $181.71 | 934,800 | |
| $186.75 | +6.04 | +3.3% | $180.72 | $188.20 | $180.00 | 1,159,800 | |
| $180.71 | +3.82 | +2.2% | $176.89 | $182.25 | $176.22 | 857,600 | |
| $176.89 | -1.30 | -0.7% | $179.10 | $179.10 | $176.29 | 1,359,700 | |
| $178.19 | +5.28 | +3.1% | $174.93 | $178.65 | $173.24 | 1,087,100 | |
| $172.91 | -1.82 | -1.0% | $174.90 | $178.55 | $171.66 | 826,900 | |
| $174.73 | +6.73 | +4.0% | $168.27 | $175.86 | $168.27 | 891,300 | |
| $168.00 | +2.82 | +1.7% | $166.74 | $168.42 | $162.10 | 514,400 | |
| $165.18 | +0.50 | +0.3% | $166.72 | $168.06 | $164.02 | 944,600 | |
| $164.68 | -0.37 | -0.2% | $162.68 | $165.04 | $161.14 | 955,900 | |
| $165.05 | -3.48 | -2.1% | $168.53 | $169.52 | $162.46 | 1,081,200 | |
| $168.53 | +0.93 | +0.6% | $168.05 | $172.95 | $166.32 | 779,400 | |
| $167.60 | -2.01 | -1.2% | $167.26 | $169.51 | $165.00 | 806,100 | |
| $169.61 | -3.33 | -1.9% | $175.53 | $176.13 | $167.54 | 1,325,300 | |
| $172.94 | +2.92 | +1.7% | $171.77 | $176.87 | $168.58 | 959,300 | |
| $170.02 | -10.96 | -6.1% | $180.70 | $182.57 | $167.42 | 1,405,100 | |
| $180.98 | +4.71 | +2.7% | $174.17 | $181.07 | $174.01 | 791,000 | |
| $176.27 | -5.76 | -3.2% | $179.76 | $181.35 | $175.70 | 818,500 | |
| $182.03 | +1.73 | +1.0% | $179.90 | $183.09 | $179.14 | 611,900 | |
| $180.30 | -1.39 | -0.8% | $180.11 | $183.43 | $179.47 | 539,100 | |
| $181.69 | +0.07 | 0.0% | $181.62 | $185.34 | $178.98 | 1,142,346 | |
| $181.62 | +0.49 | +0.3% | $180.60 | $183.05 | $176.28 | 1,497,952 | |
| $181.13 | +0.84 | +0.5% | $179.66 | $182.43 | $175.75 | 1,096,900 | |
| $180.29 | +3.93 | +2.2% | $174.61 | $188.73 | $173.14 | 1,591,700 |
- Ticker
- Xetra:RGN
- Asset type
- Stock
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Nov 4, 2026
Repligen Corporation to Present at Jefferies Global Healthcare Conference
Latest earnings call · Oct 27, 2026
Repligen (NASDAQ:RGEN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 18, 2026
Jefferies Global Healthcare Conference 2026
Conference · 30 slides
Latest news
Repligen Corporation to Present at Jefferies Global Healthcare Conference
Nov 4, 2026
Closed $178.20 (0.0%) on Nov 4, 2026
Repligen Announces $1 Billion Private Convertible Senior Notes Transaction
Oct 30, 2026
Closed $176.94 (-6.2%) on Oct 30, 2026
Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
Oct 27, 2026
Closed $175.80 (-2.4%) on Oct 27, 2026
Repligen to Report Third Quarter 2026 Financial Results
Oct 13, 2026
Closed $175.42 (+1.7%) on Oct 13, 2026
Repligen Completes Acquisition of BioLife Solutions
Oct 6, 2026
Closed $174.86 (-7.7%) on Oct 6, 2026
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Aug 26, 2026
Closed $180.30 (-0.8%) on Aug 26, 2026
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
Jul 28, 2026
Closed $145.34 (+10.9%) on Jul 28, 2026
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
Jul 22, 2026
Closed $140.09 (+2.3%) on Jul 22, 2026
Repligen to Report Second Quarter 2026 Financial Results
Jul 15, 2026
Closed $148.06 (+0.6%) on Jul 15, 2026
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
May 22, 2026
Closed $115.06 (+1.5%) on May 22, 2026
Repligen Corporation on 6ix
- News releases
- 23 in the last 12 months · 130 in all · newest Nov 4, 2026 · oldest 2017
- Calls
- 25 calls with a replay · 25 with a transcript · latest Oct 27, 2026
- Decks
- 27 decks · latest Nov 18, 2026
Where Repligen Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RGEN · Home listing | NASDAQ | United States | USD |
| gettex:RGN | gettex | Germany | EUR |
| Tradegate:RGN | Tradegate | Germany | EUR |
| LS Exchange:870980 | LS Exchange | Germany | EUR |
| Lang & Schwarz:870980 | Lang & Schwarz | Germany | EUR |
| B3:R2GE34 | B3 | Brazil | BRL |
| Frankfurt:RGN | Frankfurt | Germany | EUR |
| Milan:1RGEN | Milan | Italy | EUR |
| BOATS:RGEN | BOATS | United States | USD |
| BX Swiss:RGN | BX Swiss | Switzerland | CHF |
| Dusseldorf:RGN | Dusseldorf | Germany | EUR |
| Munich:RGN | Munich | Germany | EUR |
| Stuttgart:RGN | Stuttgart | Germany | EUR |
| Xetra:RGN · This page | Xetra | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $10.16B USD
- P/E
- Loss
- EV/sales
- 12.6×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 5.0×
- Gross margin
- 53.5%
- Operating margin
- 2.3%
- Net margin
- −1.5%
- Debt to equity
- 0.3×
- Beta vs S&P 500
- 1.19
Forecasts
14 strong buy · 3 buy · 4 hold · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 203.21 USD · Analysts' mean
- EPS, year to Dec 2026
- 2.07 · 20 analysts
- Revenue, year to Dec 2026
- 848.8M · 20 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Olivier Loeillot | Preseident and Chief Executive Officer |
| Jason K. Garland | Chief Financial Officer |
| James R. Bylund | Chief Operating Officer |
| George Scott | Senior Vice President, General Counsel |
| Jacob Johnson | VP, Investor Relations |
| Brian Douglass | Senior Vice President and Chief Product Officer |
| Greg Titus | Senior Vice President, Commercial Development |
| Jessica Hameline | Senior Vice President, Business Development & Strategy |
| Keng Hock Chua | Senior Vice President, Commercial for Asia |
| Leslie Galvin | Vice President, Global Head, Human Resources |
| Neil Whitfield | Senior Vice President, Sales |
| Ralf Kuriyel | Senior Vice President, Research and Development |
| Heather Ems | Chief Information Officer |
| Violetta Hughes | Chief Accounting Officer |
Board
| Director | Role |
|---|---|
| Martin D. Madaus | Chair of the Board |
| Carrie Eglinton Manner | Director |
| Glenn P. Muir | Director |
| Konstantin Konstantinov | Director |
| Maggie A. Pax | Director |
| Nicolas M. Barthelemy | Director |
| Rohin Mhatre | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Repligen (NASDAQ:RGEN) Q3 2026 Earnings Call | Tue, Oct 27, 2026 · 8:00 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q2 2026 Earnings Call | Tue, Jul 28, 2026 · 8:00 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q1 2026 Earnings Call | Tue, May 05, 2026 · 8:00 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 8:30 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q3 2025 Earnings Call | Tue, Oct 28, 2025 · 8:30 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q2 2025 Earnings Call | Tue, Jul 29, 2025 · 8:30 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q1 2025 Earnings Call | Tue, Apr 29, 2025 · 8:30 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q4 2024 Earnings Call | Thu, Feb 20, 2025 · 8:30 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 8:30 AM ET | Replay |
| Repligen (NASDAQ:RGEN) Q2 2024 Earnings Call | Tue, Jul 30, 2024 · 8:30 AM ET | Replay |
All 25 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 27, 2026 · Before open | −2.4% |
| Q2 2026 | Jul 28, 2026 · Before open | +10.9% |
| Q1 2026 | May 5, 2026 · Before open | +6.3% |
| Q4 2025 | Feb 25, 2026 | −0.8% |
| Q3 2025 | Oct 28, 2025 · Before open | −5.9% |
| Q2 2025 | Jul 29, 2025 · Before open | +4.7% |
| Q1 2025 | Apr 29, 2025 · Before open | −2.9% |
| Q4 2024 | Feb 19, 2025 · Before open | +3.8% |
| Q3 2024 | Nov 12, 2024 · Before open | +6.5% |
| Q2 2024 | Jul 30, 2024 · Before open | +16.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 1, 2024 · Before open | −3.6% |
| Q4 2023 | Feb 21, 2024 · Before open | −2.8% |
| Q3 2023 | Oct 31, 2023 · Before open | +17.9% |
| Q2 2023 | Aug 2, 2023 · Before open | +2.0% |
| Q1 2023 | May 2, 2023 · Before open | +2.4% |
| Q4 2022 | Feb 22, 2023 · Before open | −4.5% |
| Q3 2022 | Nov 1, 2022 · Before open | +1.7% |
| Q2 2022 | Aug 2, 2022 · Before open | +11.7% |
| Q1 2022 | Apr 27, 2022 · Before open | +10.5% |
| Q4 2021 | Feb 17, 2022 · Before open | −0.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Jefferies Global Healthcare Conference 2026 | Conference | 30 slides | Nov 18, 2026 |
| Wells Fargo 21st Annual Healthcare Conference 2026 | Conference | 32 slides | September 2026 |
| Q2 2026 Earnings Presentation | Earnings | 29 slides | Jul 28, 2026 |
| Merger or Acquisition (July 2026) | Merger or acquisition | 14 slides | Jul 22, 2026 |
| J.P. Morgan 2026 Healthcare Conference | Conference | 28 slides | Jan 13, 2026 |
| Investor Presentation (November 2025) | Investor deck | 33 slides | November 2025 |
| Bank of America Global Healthcare Conference 2025 | Conference | 28 slides | Sep 25, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 38 slides | Apr 29, 2025 |
| Merger or Acquisition (March 2025) | Merger or acquisition | 11 slides | Mar 4, 2025 |
| J.P. Morgan 43rd Annual Healthcare Conference 2025 | Conference | 33 slides | Jan 14, 2025 |
All 27 decks
Financings
| Raise | Date |
|---|---|
| 0.25% Convertible Senior Notes due 2031 Announced: about US$458.6M · J. Wood Capital Advisors LLC Dealers: J. Wood Capital Advisors LLC (lead) Use of proceeds: About $120.0 million to repurchase common stock from certain note purchasers; remainder for working capital and general corporate purposes, including possible acquisitions | Oct 30, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 738.3M | 634.4M | 632.4M | 801.5M | 670.5M | 366.3M | 270.2M | 194.0M | 141.2M | 104.5M |
| Cost of revenue | 352.0M | 359.8M | 353.9M | 345.8M | 279.3M | 156.6M | 119.1M | 86.5M | 67.0M | 47.1M |
| Gross profit | 386.2M | 274.6M | 278.4M | 455.7M | 391.3M | 209.6M | 151.1M | 107.5M | 74.2M | 57.4M |
| Research and development | 54.2M | 43.2M | 42.7M | 43.9M | 34.3M | 20.2M | 19.4M | 15.8M | 8.67M | 7.36M |
| Selling, general and administrative | 290.5M | 263.4M | 218.6M | 215.8M | 183.9M | 119.6M | 95.6M | 65.7M | 51.5M | 30.9M |
| Operating income | 55.2M | -35.1M | 47.7M | 224.7M | 167.2M | 69.8M | 36.1M | 26.0M | 14.0M | 16.0M |
| Depreciation and amortization | 78.7M | 69.7M | 68.6M | 51.0M | 38.4M | 27.1M | 20.9M | 15.8M | 10.5M | 5.33M |
| EBITDA | 133.9M | 34.6M | 116.3M | 275.7M | 205.7M | 96.9M | 57.0M | 41.8M | 24.5M | 21.3M |
| Interest expense | 21.5M | 20.7M | 1.95M | 1.16M | 11.3M | 10.8M | 9.29M | 6.71M | 6.44M | 3.77M |
| Income before tax | 62.4M | -27.0M | 56.7M | 219.1M | 153.5M | 59.2M | 26.2M | 21.4M | 7.25M | 11.7M |
| Income tax | 13.5M | -1.52M | 21.1M | 33.2M | 25.3M | -709.0K | 4.74M | 4.82M | -21.1M | 11.0K |
| Net income | 48.9M | -25.5M | 35.6M | 186.0M | 128.3M | 59.9M | 21.4M | 16.6M | 28.4M | 11.7M |
| Earnings per share, basic | 0.87 | -0.46 | 0.64 | 3.35 | 2.33 | 1.14 | 0.44 | 0.38 | 0.74 | 0.35 |
| Earnings per share, diluted | 0.86 | -0.46 | 0.63 | 3.24 | 2.24 | 1.11 | 0.44 | 0.37 | 0.72 | 0.34 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 566.0M | 757.4M | 751.3M | 523.5M | 603.8M | 717.3M | 528.4M | 193.8M | 173.8M | 122.2M |
| Short-term investments | 201.6M | 0 | 0 | 0 | ||||||
| Receivables | 158.6M | 134.1M | 124.2M | 116.2M | 117.4M | 71.4M | 43.1M | 33.0M | 27.6M | 15.2M |
| Inventory | 170.5M | 143.0M | 202.3M | 238.3M | 184.5M | 95.0M | 54.8M | 42.3M | 39.0M | 24.7M |
| Current assets | 1.14B | 1.07B | 1.11B | 998.1M | 931.7M | 902.4M | 641.8M | 275.7M | 242.8M | 184.2M |
| Property, plant and equipment | 186.6M | 197.7M | 207.4M | 190.7M | 125.0M | 66.9M | 48.5M | 32.2M | 22.4M | 15.0M |
| Goodwill | 1.11B | 1.03B | 987.1M | 855.5M | 860.4M | 618.3M | 468.4M | 326.7M | 327.3M | 59.5M |
| Total assets | 2.95B | 2.83B | 2.83B | 2.53B | 2.36B | 1.90B | 1.40B | 774.6M | 743.5M | 288.9M |
| Accounts payable | 30.0M | 32.1M | 19.6M | 27.6M | 36.2M | 16.9M | 11.4M | 10.5M | 7.28M | 5.06M |
| Current liabilities | 135.8M | 126.8M | 164.9M | 404.2M | 375.3M | 319.0M | 48.3M | 129.8M | 25.2M | 21.1M |
| Total debt | 542.2M | 525.6M | ||||||||
| Total liabilities | 843.6M | 856.9M | 866.3M | 620.9M | 608.3M | 373.7M | 340.3M | 159.1M | 152.0M | |
| Shareholders' equity | 2.11B | 1.97B | 1.96B | 1.91B | 1.75B | 1.53B | 1.06B | 615.6M | 591.5M | 168.8M |
| Shares outstanding | 56.3M | 56.1M | 55.8M | 55.6M | 55.3M | 54.8M | 52.1M | 43.9M | 43.6M | 33.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 117.4M | 175.4M | 113.9M | 172.1M | 119.0M | 62.6M | 67.2M | 32.8M | 17.5M | 7.52M |
| Capital spending | -23.5M | -25.7M | -36.2M | -84.8M | -67.1M | -22.5M | -18.5M | -10.6M | -5.45M | -4.33M |
| Free cash flow | 93.9M | 149.7M | 77.7M | 87.2M | 51.9M | 40.2M | 48.7M | 22.1M | 12.0M | 3.20M |
| Cash from investing | -298.5M | -86.4M | -123.3M | -233.2M | -221.2M | -201.4M | -205.3M | -14.0M | -98.7M | -49.2M |
| Cash from financing | -15.2M | -82.9M | 249.0M | -13.3M | 961.0K | 305.9M | 484.9M | 3.41M | 129.9M | 112.1M |
| Share buybacks | 0 | 0 | -14.4M | 0 | 0 | |||||
| Change in cash | -191.3M | 6.03M | 227.9M | -80.4M | -113.5M | 179.9M | 343.6M | 20.1M | 51.1M | 68.1M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 6, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Oct 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 30, 2026 | Financing | SEC |
| 8-K · Current report | Oct 27, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 8, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 7, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 6, 2026 | Acquisition or disposal | SEC |
| 144 · Notice of proposed sale | Oct 5, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Oct 5, 2026 | Other filings | SEC |
| 425 | Sep 30, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 24, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 22, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 21, 2026 | Other filings | SEC |
| 8-K · Current report | Sep 15, 2026 | Management or board change | SEC |
| 425 | Sep 8, 2026 | Other filings | SEC |
| 8-K · Current report | Sep 8, 2026 | Current report | SEC |
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Sep 8, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Sep 4, 2026 | Offer document | SEC |
| 144 · Notice of proposed sale | Sep 4, 2026 | Other filings | SEC |
| S-4/A · Registration statement, amended | Sep 3, 2026 | Offer document | SEC |
| 4 · Change in ownership | Sep 2, 2026 | Insider trade | SEC |
| S-4 · Registration statement | Aug 24, 2026 | Offer document | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 20, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 425 | Aug 3, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 31, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Jul 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 28, 2026 | Results | SEC |
| 425 | Jul 23, 2026 | Other filings | SEC |
| 425 | Jul 22, 2026 | Other filings | SEC |
| 425 | Jul 22, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 22, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 26, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 25, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 8-K · Current report | May 15, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| DEFA14A · Additional proxy material | Apr 27, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 22, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 21, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Apr 2, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 2, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 2, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 5, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 6, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Dec 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 17, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 25, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 13, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 28, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 10, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 10, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 8, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 4, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 2, 2025 | Management or board change | SEC |
| CORRESP · Letter to the SEC | Aug 26, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 14, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2025 | Results | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 8-K · Current report | May 15, 2025 | Meeting outcome | SEC |
| 144 · Notice of proposed sale | May 15, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Apr 29, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 29, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 24, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 4, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 4, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 4, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2025 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Mar 17, 2025 | Meeting notice | SEC |
| 144 · Notice of proposed sale | Mar 17, 2025 | Other filings | SEC |
| 10-K · Annual report | Mar 13, 2025 | Annual report | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| NT 10-K · Late filing notice | Mar 3, 2025 | Explanation request | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 20, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 22, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 21, 2024 | Other filings | SEC |
| 4 · Change in ownership | Nov 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 18, 2024 | Quarterly report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 18, 2024 | Quarterly report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 18, 2024 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | Nov 18, 2024 | Annual report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 18, 2024 | Quarterly report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 18, 2024 | Quarterly report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 18, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| NT 10-Q · Late filing notice | Nov 12, 2024 | Explanation request | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Nov 12, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Oct 23, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Sep 18, 2024 | Results | SEC |
| 4 · Change in ownership | Sep 12, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Sep 10, 2024 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Sep 10, 2024 | Other filings | SEC |
| 4 · Change in ownership | Sep 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Aug 19, 2024 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Aug 12, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 6, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 5, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 2, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 1, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 1, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 1, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 30, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2024 | Results | SEC |
| UPLOAD · Letter from the SEC | Jul 24, 2024 | Other filings | SEC |
| 8-K · Current report | Jul 15, 2024 | Current report | SEC |
| 4 · Change in ownership | Jun 14, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 14, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 14, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 14, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 14, 2024 | Management or board change | SEC |
| 8-K · Current report | Jun 13, 2024 | Current report | SEC |
| 4 · Change in ownership | May 22, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 21, 2024 | Other filings | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
This page holds 200 of 1,004 filings. Open Filings
Cap table
Built by 6ix from Repligen Corporation’s releases · as of Oct 30, 2026
- Common shares
- 63,923,738
- Fully diluted
- 63,923,738
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 63,923,738 | Oct 23, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 23, 2026 | 63,923,738 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Glenn P. Muir Other companies: Cytek Biosciences, Inc. (Director · Since at least Jun 10, 2026); Neuronetics, Inc. (Board Member · Since at least Jun 27, 2018); G1 Therapeutics Inc (Director · May 16, 2017 – Sep 18, 2024 · Past); Lifeward Ltd. (Director · Dec 31, 2015 – Jun 27, 2017 · Past); Hologic Inc (Executive VP and CFO · Feb 1, 2006 – May 8, 2014 · Past) | Director · Since at least Sep 14, 2015 |
| Paul Schimmel Other companies: aTyr Pharma, Inc. (Director · Since at least May 6, 2015); Alnylam Pharmaceuticals, Inc. (Co-founder and member of the Board of Directors · Since at least Jan 31, 2006); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – Nov 30, 2007 · Past); Alkermes plc (Director · Mar 2, 2006 – Jun 15, 2007 · Past) | Director · Aug 11, 2006 – Jun 14, 2007 · Past |
| John Cox Other companies: Dyne Therapeutics, Inc. (President and Chief Executive Officer · Since at least Mar 25, 2024); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Bioverativ Inc (Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past) | Director · Nov 15, 2013 – Mar 24, 2020 · Past |
| Nicolas M. Barthelemy Other companies: 908 Devices Inc. (Director · Dec 17, 2020 – Jun 15, 2022 · Past); Twist Bioscience Corporation (Director · Oct 24, 2019 – Nov 21, 2022 · Past); Standard BioTools Inc. (Director · Mar 23, 2017 – Apr 1, 2022 · Past) | Director · Since at least May 11, 2016 |
| Martin Madaus Other companies: Azenta, Inc. (interim President and CEO · Since Aug 24, 2026); Haemonetics Corporation (Director · Since at least Jul 24, 2026) | Chair of the Board · Since at least Jan 6, 2026 |
| Tony Hunt Other companies: BioLife Solutions, Inc. (Director · Since at least Dec 20, 2024); 908 Devices Inc. (Director · Since at least Mar 2, 2022) | Director · Since at least Nov 19, 2020 |
| Glenn L Md Cooper Other companies: Fortress Biotech, Inc. (See Remarks, Director · Sep 13, 2011 – Nov 30, 2012 · Past) | Director · Sep 16, 2010 – May 23, 2019 · Past |
| Manner Carrie Eglinton Other companies: OraSure Technologies, Inc. (President & CEO, Director · Since at least Jun 4, 2025) | Director · Since at least May 15, 2025 |
| Margaret Pax Other companies: Alimera Sciences Inc (Director · Nov 7, 2023 – Sep 16, 2024 · Past) | Director · Since at least Mar 18, 2024 |
| Rohin Mhatre Other companies: Parabilis Medicines, Inc. (Chief Technical Operations Officer · Since at least Jun 9, 2026) | Director · Since at least Mar 1, 2020 |
All 36 people
| Person | Seat |
|---|---|
| Violetta Hughes Other companies: Azenta, Inc. (VP, Chief Accounting Officer · Aug 31, 2023 – Feb 3, 2025 · Past) | Chief Accounting Officer · Since at least Sep 1, 2025 |
| Alexander Rich | Director · Dec 15, 2011 – Dec 15, 2011 · Past |
| Alfred Lewis Goldberg | Director · Jul 1, 2008 – May 21, 2015 · Past |
| Brian Douglass | Senior Vice President and Chief Product Officer · Since at least May 7, 2026 |
| Carrie Eglinton Manner | Director · Since at least Nov 5, 2026 |
| Christine Gebski | See Remarks · Feb 25, 2021 – May 14, 2024 · Past |
| Earl Webb Henry | Director · Dec 12, 2007 – May 9, 2013 · Past |
| George Scott | Senior Vice President, General Counsel · Since at least Nov 4, 2026 |
| Greg Titus | Senior Vice President, Commercial Development · Since at least Nov 4, 2026 |
| Hal Landy | Vice President · Jun 19, 2007 – Jun 19, 2007 · Past |
| Heather Ems | Chief Information Officer · Since at least Nov 4, 2026 |
| Jacob Johnson | VP, Investor Relations · Since at least Apr 8, 2025 |
| James R. Bylund | Chief Operating Officer · Since at least Feb 25, 2021 |
| Jason K. Garland | Chief Financial Officer · Since at least Jun 25, 2026 |
| Jessica Hameline | Senior Vice President, Business Development & Strategy · Since at least Nov 4, 2026 |
| Jon Snodgres | Chief Financial Officer · Jul 14, 2015 – May 16, 2023 · Past |
| Karen A Dawes | Director · Since at least Feb 27, 2024 |
| Keng Hock Chua | Senior Vice President, Commercial for Asia · Since at least Nov 4, 2026 |
| Konstantin Konstantinov | Director · Since at least May 18, 2026 |
| Leslie Galvin | Vice President, Global Head, Human Resources · Since at least Nov 4, 2026 |
| Maggie A. Pax | Director · Since at least May 18, 2026 |
| Michael Hall | Chief Medical Officer · Mar 12, 2012 – Mar 12, 2012 · Past |
| Neil Whitfield | Senior Vice President, Sales · Since at least Nov 4, 2026 |
| Olivier Loeillot | Preseident and Chief Executive Officer · Since at least Oct 2, 2023 |
| Ralf Kuriyel | Senior Vice President, Research and Development · Since at least Feb 28, 2018 |
| Thomas F Ryan Jr | Director · Dec 9, 2005 – Mar 1, 2022 · Past |
Log in to ask 6ix AI your own questions about Repligen Corporation.